TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$58.45
+3.09% today
Updated 2026-04-30
Market cap
$3.48B
P/E ratio
—
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$23 – $66
Volume
1.2M
Twist Bioscience Corp (TWST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-19.60%
Operating margin
-31.70%
ROE
-16.80%
ROA
-13.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $2.27M | $-44.09M | -315.20% | -1,924.02% | -1,943.06% |
| 2017 | $10.77M | $-59.31M | -123.09% | -543.16% | -550.85% |
| 2018 | $25.43M | $-71.24M | -26.59% | -277.50% | -280.16% |
| 2019 | $54.38M | $-107.67M | 12.80% | -200.15% | -197.98% |
| 2020 | $90.10M | $-139.93M | 31.85% | -155.47% | -155.31% |
| 2021 | $132.33M | $-152.10M | 39.08% | -115.41% | -114.94% |
| 2022 | $203.56M | $-217.86M | 41.38% | -122.33% | -107.02% |
| 2023 | $245.11M | $-204.62M | 36.61% | -88.60% | -83.48% |
| 2024 | $312.97M | $-208.73M | 42.61% | -70.56% | -66.69% |
| 2025 | $376.57M | $-77.67M | 50.72% | -36.18% | -20.63% |